Gender Identity and Health-related Outcomes in a National Sample of College Students

Dinger, Mary K.; Brittain, Danielle R.; Patten, Luke; Hall, Kelly C.; Burton, Steven L.; Hydock, David S.; Stellino, Megan Babkes

doi:10.1080/19325037.2020.1822242

Cited by 3 publications

(6 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Both the Q index and the Galbraith graph indicated the presence of data heterogeneity. The data from De Pedro (2017) [35], Gamarel (2020) [38], and Azagba (2019) [29] for cigarettes and Kelly (2015) [42] and Dinger (2020) [36] for e-cigarettes contributed the most heterogeneity to this current study. Despite this heterogeneity, our sensitivity analysis showed that by removing each of these articles, the OR changed very little, and the precision did not increase (Figure 2).…”

Section: Current Tobacco Use and Tobacco Use Disordermentioning

confidence: 80%

“…In this sense, as shown in Figure 3, the Q index was 34.90 (p < 0.001), which along with the Galbraith graphic, indicated the presence of heterogeneity. The data from Aparicio-García (2018) [28], De Pedro (2017) [35], and Dinger (2020) [36] contributed most of the heterogeneity. Sensitivity analysis showed that removing each of these items changed the OR very little, although a subgroup analysis in which these three items were excluded to remove this heterogeneity (Q = 5.90; p = 0.315) resulted in a slightly higher pooled OR of 1.03 (95% CI [0.93, 1.15]).…”

Section: Current Alcohol Use and Alcohol Use Disordermentioning

confidence: 95%

“…A meta-analysis was completed for the relationship between identifying as transgender and substance types and use (current use, current use disorder, and lifetime use). Table 1 shows the characteristics of the studies included in these meta-analyses [12,19,[28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45], which were all in English and included both sexes assigned at birth: male and female.…”

Section: Studies Includedmentioning

confidence: 99%

“…Both the Q index and the Galbraith graphs indicated the presence of data heterogeneity. Data from De Pedro (2017) [35], Batchelder (2021) [30], Jun (2019) [41], Day (2017) [12], Stanton (2021) [44], and Dinger (2020) [36] contributed the most to the data heterogeneity, although sensitivity analysis showed that removing each of these items changed the OR very little (Figure 4). Moreover, a subgroup analysis in which these items were excluded to remove the heterogeneity (Q = 2.86; p = 0.412) did not substantially change the pooled OR of 1.01 (95% CI [0.69, 1.28]).…”

Section: Current Alcohol Use and Alcohol Use Disordermentioning

confidence: 99%

“…In addition, the Q index was 245.71 (p < 0.001) and, when considered with the Galbraith graphic, showed high heterogeneity, which was expected given the variety of the substances included in the analysis. Thus, we excluded the data that contributed the most to this heterogeneity: all the data from De Pedro (2017) [35] and Carone (2020) [32] for drugs; Aparicio (2018) [28] for drugs; Flentje (2014) [37] for cocaine, marijuana, heroin, and other drugs; Cohan (2006) [33] for cocaine/crack and any illicit drugs; Dinger (2020) [36] for inhalants, other club drugs, and marijuana; Day (2017) [12] for other drugs; and Hawke (2021) [39] for intra-COVID substance use. As shown in Figure 6, when we performed the sub-analysis with the resulting subgroup, the heterogeneity was eliminated (Q = 31.95; p = 0.059), and the pooled OR increased to 2.11 (95% CI [1.77, 2.51]; the cisgender/transgender ratio was 1:2.11).…”

Section: Current Substance (Excluding Tobacco and Alcohol) Use And Us...mentioning

confidence: 99%

See 4 more Smart Citations

Substance Use in the Transgender Population: A Meta-Analysis

et al. 2022

View full text Add to dashboard Cite

(1) Background: This meta-analysis aimed to assess the relationship between identifying as transgender and substance use. (2) Methods: We searched for relevant studies in PubMed, Scopus, the Web of Science, and PsycINFO on 21 July 2021. (3) Results: Twenty studies comparing transgender and cisgender people were included in this work, accounting for a total of 2,376,951 participants (18,329 of whom were transgender). These articles included data on current tobacco use, current tobacco use disorder, current alcohol use, current alcohol use disorder, lifetime substance (all) use, current substance use (excluding tobacco and alcohol), current use of specific substances (excluding tobacco and alcohol and including cocaine, amphetamines, methamphetamines, ecstasy, stimulants, heroin, opiates, cannabis, marijuana, LSD, hallucinogens, steroids, inhalants, sedatives, Ritalin or Adderall, diet pills, cold medicine, prescription medications, polysubstance, other club drugs, and other illegal drugs), and current substance use disorder (excluding tobacco and alcohol). We used the ORs and their 95% CIs to state the association between identifying as transgender and those variables. The control reference category used in all cases was cisgender. We employed a random-effects model. Transgender people were more likely to use tobacco (odds ratio (OR) = 1.65; 95% CI [1.37, 1.98]), have used substances throughout their lives (OR = 1.48; 95% CI [1.30, 1.68]), and present current use of specific substances (OR = 1.79; 95% CI [1.54, 2.07]). When current alcohol and substance use in general and tobacco, alcohol, and substance use disorders specifically were considered, the likelihood did not differ from that of cisgender people. (4) Conclusions: The presence of substance use disorders did not differ between transgender and cisgender people. Considering this population as consumers or as addicted may be a prejudice that perpetuates stigma. Nonetheless, transgender people were more likely to use tobacco and other substances, but not alcohol. Hypothetically, this might be an emotional regulation strategy, a maladaptive mechanism for coping with traumatic experiences, or could respond to minority stress, produced by stigma, prejudice, discrimination, and harassment. It is of particular importance to implement policies against discrimination and stigmatisation and to adapt prevention and treatment services so that they are inclusive of the 2SLGBTQIA+ community.

show abstract